Feasibility and acceptance of salivary monitoring of antiepileptic drugs via the US Postal Service

Therapeutic Drug Monitoring

Volumn 26, Issue 3, 2004, Pages 295-299

  Tennison, Michael ^a   Ali, Imran ^b   Miles, Michael V ^c   D'Cruz, O'Neill ^a   Vaughn, Bradley ^a   Greenwood, Robert ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b MEDICAL COLLEGE OF OHIO   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Antiepileptic drug; Mail; Saliva

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; PHENOBARBITAL; PHENYTOIN;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; CHILD; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG MONITORING; DRUG SALIVA LEVEL; EPILEPSY; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; FREEZING; HOME MONITORING; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTAL MAIL; PRIORITY JOURNAL; RELIABILITY; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; DRUG MONITORING; EPILEPSY; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; PATIENT SATISFACTION; POSTAL SERVICE; SALIVA; SPECIMEN HANDLING;

EID: 2542586177     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-200406000-00013     Document Type: Article

References (12)

1. Choonara IA, Rane A. Therapeutic drug monitoring of anticonvulsants. State of the art. Clin Pharmacokinet. 1990;18:318-328.
2. Drobitch RK, Svensson CK. Therapeutic drug monitoring in saliva. An update. Clin Pharmacokinet. 1992;23:365-379.
3. Gorodischer R, Koren G. Salivary excretion of drugs in children: theoretical and practical issues in therapeutic drug monitoring. Dev Pharmacol Ther. 1992;19:161-177.
4. Liu H, Delgado MR. Therapeutic drug concentration monitoring using saliva samples. Focus on anticonvulsants. Clin Pharmacokinet. 1999;36:453-470.
5. Miles MV, Tennison MB, Greenwood RS, et al. Evaluation of the Ames Seralyzer for the determination of carbamazepine, phenobarbital, and phenytoin concentrations in saliva. Ther Drug Monit. 1990;12:501-510.
6. Miles MV, Tennison MB, Greenwood RS. Intraindividual variability of carbamazepine, phenobarbital, and phenytoin concentrations in saliva. Ther Drug Monit. 1991;13:166-171.
7. Mucklow JC, Bacon CJ, Hierons AM, et al. Monitoring of phenobarbitone and phenytoin therapy in small children by salivary samples. Ther Drug Monit. 1981;3:275-277.
8. Levy RH, Schmidt D. Utility of free level monitoring of antiepileptic drugs. Epilepsia. 1985;26:199-205.
9. Rosenthal E, Hoffer E, Ben-Aryeh H, et al. Use of saliva in home monitoring of carbamazepine levels. Epilepsia. 1995;36:72-74.
10. Dickinson RG, Hooper WD, King AR, et al. Fallacious results from measuring salivary carbamazepine concentrations. Ther Drug Monit. 1985;7:41-45.
11. Schramm W, Smith RH. An ultrafiltrate of saliva collected in situ as a biological sample for diagnostic evaluation. Clin Chem. 1991;37:114-115.
12. Gorodischer R, Burtin P, Verjee Z, et al. Is saliva suitable for therapeutic monitoring of anticonvulsants in children: an evaluation in the routine clinical setting. Ther Drug Monit. 1997;19:637-642.